CNBC Fast Money Stock Picks to Watch 6/26/08
Joe Terranova: Opinions
Want to get long the dollar? Buy UUP
Nucor NUE: I think you can buy this stock here
Pete Najarian: Opinions
Markets: QID - If you think the markets are going down...you buy this stock
ANR: I added to this today on the long side....continues to work
Nike NKE: I like NKE right here on the long side
COP: This stock is cheap....its trading way cheaper then a 12 P/E
L3 communications LLL: I think you can buy this
Guy Adami: Opinions
HAL: This stock is working...it will continue to do well
General Motors GM: You didn't see capitulation yet...it will be a buy in the next 3-4 trading day...just not yet
General Motors GM: It's not going away, I can tell you that right now.....if it goes to low someone might step ( like Kirk Kikorian sp?)
Nike NKE: you might have actually seen capitulation on NKE today
Karen Finerman: Opinions
Citigroup C: I was early buying this stock I didn't have my buy list out today because of Oil prices going up...I want to wait longer
Merck MRK: Its on my radar to buy
Carter Worth, Chief Market Technician, Oppenheimer & Co. Inc
Thinks market is fragile and broken.....thinks we will test 1200 on S&P average
http://oilshalegas.com http://blackberrystocks.com/fastmoney.html
Thursday, June 26, 2008
Pre Market Stock Daytrading Update 6-26-08
Citigroup might be writing down another 9 billion.....this has the Dow down 60 this morning combines with RIMM earnings that were not that good.
RIMM came in with .84 vs .85 last night. Nike NKE earnings were really bad as well.
A big mover today will be VNDA...$6 today in pre market up 20%
http://blackberrystocks.com/hotstocks.html
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic InsomniaStudy Meets Primary Endpoint, with Positive Effect Sustained Through Duration of 4-Week Study ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq VNDA Vanda) today announced positive top-line results from a Phase III trial showing that its investigational drug candidate, tasimelteon (VEC-162), a novel melatonin agonist, met the primary endpoint of the trial and significantly improved sleep in adult patients with chronic insomnia.We are excited that the results of this Phase III chronic insomnia study demonstrate the clinical utility of tasimelteon and the ability of the compound to treat sleep disorders over a period of four weeks. The mechanism of action of tasimelteon as a circadian regulator gives Vanda the opportunity to explore its use for the treatment of circadian rhythm sleep disorders as well as chronic primary insomnia," stated Paolo Baroldi, MD, PhD, Vanda's Chief Medical Officer.
This Phase III, multi-center, placebo-controlled, 4-week trial evaluated 322 patients with chronic primary insomnia. Patients were randomized to receive either 20 mg or 50 mg of tasimelteon or placebo over the course of four weeks. The primary endpoint consisted of the evaluation of the immediate and short-term (average of Nights 1 and 8) ability of tasimelteon to improve sleep onset as measured by Latency to Persistent Sleep (LPS) through polysomnography (PSG). Secondary endpoints evaluated tasimelteon's ability to maintain improvements on sleep onset after long-term (average of Nights 22 and 29) use of the compound as well as measures of sleep duration (Total Sleep Time, TST) and sleep maintenance (Wake After Sleep Onset, WASO). Patients were eligible for the study if symptoms of insomnia were chronic and LPS was greater than 30 minutes.
Significant Improvement in Sleep Onset Sustained through Study Duration
These results demonstrate that tasimelteon was able to improve LPS significantly, and that this effect persisted for the 4 week duration of the study. The results on LPS at night 1 (N1)/night 8 (N8), and night 22 (N22)/night 29 (N29) are as follows.Mean LPS at baseline (before drug treatment) was 78.8 minutes in the 20mg group, 76.4 minutes in the 50mg group, and 78.2 minutes in the placebo group. On Nights 1 and 8 of treatment, mean LPS improved by 45.0 minutes in the 20mg group (p<.001), by 46.4 minutes in the 50mg group (p<.001), and by 28.3 minutes in the placebo group. On Nights 22 and 29 of treatment, mean LPS improved by 49.4 minutes in the 20mg group (p<.001), by 45.1 minutes in the 50mg group (p=.016), and by 33.9 minutes in the placebo group. All statistical comparisons are between tasimelteon dose versus placebo.
Importantly, this effect was also seen acutely on the first night of treatment. Patients in the 20mg and 50mg groups fell asleep 22.9 minutes (p<.001) and 25.9 minutes (p<.001) faster, respectively, than those in the
placebo group, as measured objectively through PSG. Data from subjective patient self-reports on these nights were consistent with this finding
http://biz.yahoo.com/prnews/080626/neth035.html?.v=58
RIMM came in with .84 vs .85 last night. Nike NKE earnings were really bad as well.
A big mover today will be VNDA...$6 today in pre market up 20%
http://blackberrystocks.com/hotstocks.html
Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic InsomniaStudy Meets Primary Endpoint, with Positive Effect Sustained Through Duration of 4-Week Study ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq VNDA Vanda) today announced positive top-line results from a Phase III trial showing that its investigational drug candidate, tasimelteon (VEC-162), a novel melatonin agonist, met the primary endpoint of the trial and significantly improved sleep in adult patients with chronic insomnia.We are excited that the results of this Phase III chronic insomnia study demonstrate the clinical utility of tasimelteon and the ability of the compound to treat sleep disorders over a period of four weeks. The mechanism of action of tasimelteon as a circadian regulator gives Vanda the opportunity to explore its use for the treatment of circadian rhythm sleep disorders as well as chronic primary insomnia," stated Paolo Baroldi, MD, PhD, Vanda's Chief Medical Officer.
This Phase III, multi-center, placebo-controlled, 4-week trial evaluated 322 patients with chronic primary insomnia. Patients were randomized to receive either 20 mg or 50 mg of tasimelteon or placebo over the course of four weeks. The primary endpoint consisted of the evaluation of the immediate and short-term (average of Nights 1 and 8) ability of tasimelteon to improve sleep onset as measured by Latency to Persistent Sleep (LPS) through polysomnography (PSG). Secondary endpoints evaluated tasimelteon's ability to maintain improvements on sleep onset after long-term (average of Nights 22 and 29) use of the compound as well as measures of sleep duration (Total Sleep Time, TST) and sleep maintenance (Wake After Sleep Onset, WASO). Patients were eligible for the study if symptoms of insomnia were chronic and LPS was greater than 30 minutes.
Significant Improvement in Sleep Onset Sustained through Study Duration
These results demonstrate that tasimelteon was able to improve LPS significantly, and that this effect persisted for the 4 week duration of the study. The results on LPS at night 1 (N1)/night 8 (N8), and night 22 (N22)/night 29 (N29) are as follows.Mean LPS at baseline (before drug treatment) was 78.8 minutes in the 20mg group, 76.4 minutes in the 50mg group, and 78.2 minutes in the placebo group. On Nights 1 and 8 of treatment, mean LPS improved by 45.0 minutes in the 20mg group (p<.001), by 46.4 minutes in the 50mg group (p<.001), and by 28.3 minutes in the placebo group. On Nights 22 and 29 of treatment, mean LPS improved by 49.4 minutes in the 20mg group (p<.001), by 45.1 minutes in the 50mg group (p=.016), and by 33.9 minutes in the placebo group. All statistical comparisons are between tasimelteon dose versus placebo.
Importantly, this effect was also seen acutely on the first night of treatment. Patients in the 20mg and 50mg groups fell asleep 22.9 minutes (p<.001) and 25.9 minutes (p<.001) faster, respectively, than those in the
placebo group, as measured objectively through PSG. Data from subjective patient self-reports on these nights were consistent with this finding
http://biz.yahoo.com/prnews/080626/neth035.html?.v=58
Thursday, June 19, 2008
CNBC Fast Money 6-19-08 Recap
Fast Money Stock Picks to Watch 6/19/08
Jeff Mackie: Opinions
USO: Buy it, set a stop at $99
Pete Najarian: Opinions
Regional Banks: These are going lower...put activity says this...today was just short covering
SandRidge SD: When this stock fell today...someone bought Sept 80 calls, 30,000 of them....keep an eye on this stock
Guy Adami: Opinions
Oil: I think its going lower by $10-15...the China news could have put a top in
Juniper JNPR: I think you can own this stock
Joe Terranova: Opinions
S&P Support: 1320-1327
Recap of 6/18/08 Fast Money Click Here
Jeff Mackie: Opinions
USO: Buy it, set a stop at $99
Pete Najarian: Opinions
Regional Banks: These are going lower...put activity says this...today was just short covering
SandRidge SD: When this stock fell today...someone bought Sept 80 calls, 30,000 of them....keep an eye on this stock
Guy Adami: Opinions
Oil: I think its going lower by $10-15...the China news could have put a top in
Juniper JNPR: I think you can own this stock
Joe Terranova: Opinions
S&P Support: 1320-1327
Recap of 6/18/08 Fast Money Click Here
Mexco Energy MXC on CNBC Today
Mexco Energy MXC on CNBC today
CNBC has been reporting on Wildcatters of Texas.....Wildcatters research and drill for oil in parts of America...usually in the south.
Mexco Energy is one of these companies- Ticker symbol MXC
Guess what? MXC is Top Stock Largest Gainer for 2008 up over 1000%
Turns out, they are drilling this one well in Texas and are down to 13,000 feet....they think the oil is around 13,900 feet so they are soon there. Keep an eye on this company!
Also, keep an eyes on different Oil and Gas finds http://oilshalegas.com
CNBC has been reporting on Wildcatters of Texas.....Wildcatters research and drill for oil in parts of America...usually in the south.
Mexco Energy is one of these companies- Ticker symbol MXC
Guess what? MXC is Top Stock Largest Gainer for 2008 up over 1000%
Turns out, they are drilling this one well in Texas and are down to 13,000 feet....they think the oil is around 13,900 feet so they are soon there. Keep an eye on this company!
Also, keep an eyes on different Oil and Gas finds http://oilshalegas.com
Wednesday, June 18, 2008
CNBC Fast Money Recap 6-18-08 USO
Top 2008 Stock Gainers click here
Fast Money Stock Picks to Watch 6/18/08
Jeff Mackie: Opinions
HMO Stocks: Don't fight the tape...UNH
Railroad Stocks: Floods are going away soon...buy the rails because of coal shipments
USO: Buy it, set a stop at $100
Pete Najarian: Opinions
Morgan Stanley MS: Bought the Financials today....
Regional Financial RF: Options Activity says more downside
Burlington Northern BNI: Great opportunity to buy this and the rail stocks...the flooding will go away
MYGN: Keep an eye on this....they continue to buy the july calls
Coal EFT KOL: I don't think this coal story is over....I think it can go higher
Guy Adami: Opinions
Morgan Stanley MS: Look for another 10-15% upside....it bottomed. Stop $37.50
Fed Ex FDX: You could easily see this go to $87-88 in the short term
XTO Energy XTO: I still think it goes higher
Deere DE: I think this stock can go a lot higher
Agrium AG: Given fertilizer prices I think this stock can go higher
Joe Terranova: Opinions
XLF: I bought this today.....I think you can start to buy financials
Oil: Friday is options expiration...look for it to go to $140
Recap of 6/17/08 Fast Money Click Here
Fast Money Stock Picks to Watch 6/18/08
Jeff Mackie: Opinions
HMO Stocks: Don't fight the tape...UNH
Railroad Stocks: Floods are going away soon...buy the rails because of coal shipments
USO: Buy it, set a stop at $100
Pete Najarian: Opinions
Morgan Stanley MS: Bought the Financials today....
Regional Financial RF: Options Activity says more downside
Burlington Northern BNI: Great opportunity to buy this and the rail stocks...the flooding will go away
MYGN: Keep an eye on this....they continue to buy the july calls
Coal EFT KOL: I don't think this coal story is over....I think it can go higher
Guy Adami: Opinions
Morgan Stanley MS: Look for another 10-15% upside....it bottomed. Stop $37.50
Fed Ex FDX: You could easily see this go to $87-88 in the short term
XTO Energy XTO: I still think it goes higher
Deere DE: I think this stock can go a lot higher
Agrium AG: Given fertilizer prices I think this stock can go higher
Joe Terranova: Opinions
XLF: I bought this today.....I think you can start to buy financials
Oil: Friday is options expiration...look for it to go to $140
Recap of 6/17/08 Fast Money Click Here
Tuesday, June 17, 2008
Fast Money Recap stock picks 6-17-08 CNBC Visa V MON AMZN
Top 2008 Stock Gainers - http://blackberrystocks.com/topstocks.html
Haynesville Shale Stocks - http://oilshalegas.com/haynesvilleshalestocks.html
Fast Money Stock Picks to Watch 6/17/08
Jeff Mackie: Opinions
Financials: Going lower...the rally is over...MS reports tomorrow, that will be hideous
USO: Stick with what is working....USO is working
Pete Najarian: Opinions
Regions Financial RF: Put activity was strong today...looking for more downside
Morgan Stanley MS: Very active put options
Visa V MasterCard MA: You want to play financials, buy these....I like Visa
CAT: This stock is to cheap
FSLR: Buying the dip....FSLR doesn't sell in the USA so it shouldn't have gone down on the vote
Elan Corp ELN: Keep an eye on this stock....as well as MYGN
Guy Adami: Opinions
Goldman Sachs GS: Goldman had a monster run but we told you to take profits
Morgan Stanley MS: I might be out of my mind, but I think its a buy
Monsanto MON: The upside isn't done yet
Joe Terranova: Opinions
Housing starts: Was bad today
Oil: If Oil doesn't go down after June 22nd meeting, how can it
Natural Gas: The trade continues to be buy natural gas
Nymex NMX: I want to own NMX and NYX....they are the new casino stocks....volumes are good
Amazon.com AMZN: I like AMZN....
Goldman Sachs thinks it can go to $98
Monsanto MON: Broke through $140...here comes $150
Dryships DRYS: I call it a recovery rebound...don't read to much into it
Recap of 6/16/08 Fast Money Click Here
Haynesville Shale Stocks - http://oilshalegas.com/haynesvilleshalestocks.html
Fast Money Stock Picks to Watch 6/17/08
Jeff Mackie: Opinions
Financials: Going lower...the rally is over...MS reports tomorrow, that will be hideous
USO: Stick with what is working....USO is working
Pete Najarian: Opinions
Regions Financial RF: Put activity was strong today...looking for more downside
Morgan Stanley MS: Very active put options
Visa V MasterCard MA: You want to play financials, buy these....I like Visa
CAT: This stock is to cheap
FSLR: Buying the dip....FSLR doesn't sell in the USA so it shouldn't have gone down on the vote
Elan Corp ELN: Keep an eye on this stock....as well as MYGN
Guy Adami: Opinions
Goldman Sachs GS: Goldman had a monster run but we told you to take profits
Morgan Stanley MS: I might be out of my mind, but I think its a buy
Monsanto MON: The upside isn't done yet
Joe Terranova: Opinions
Housing starts: Was bad today
Oil: If Oil doesn't go down after June 22nd meeting, how can it
Natural Gas: The trade continues to be buy natural gas
Nymex NMX: I want to own NMX and NYX....they are the new casino stocks....volumes are good
Amazon.com AMZN: I like AMZN....
Goldman Sachs thinks it can go to $98
Monsanto MON: Broke through $140...here comes $150
Dryships DRYS: I call it a recovery rebound...don't read to much into it
Recap of 6/16/08 Fast Money Click Here
6.17.08 Stock Market Day Trading Update
This morning the market is up on Goldman Sachs GS earnings.....$4.58 per share vs $3.42
CSIQ and DRYS Dry Ships are moving up in pre market.
Two guests on CNBC have just talked about the recent Drys dip was a big buying opportunity. They think it has substantial upside from here.
JRCC and PCX are tearing up my Top 2008 Stocks list...do your research on them!
Discover Oil and Gas companies on the move with key drilling finds
http://oilshalegas.com
CSIQ and DRYS Dry Ships are moving up in pre market.
Two guests on CNBC have just talked about the recent Drys dip was a big buying opportunity. They think it has substantial upside from here.
JRCC and PCX are tearing up my Top 2008 Stocks list...do your research on them!
Discover Oil and Gas companies on the move with key drilling finds
http://oilshalegas.com
Subscribe to:
Posts (Atom)
